kh5.jpg

ORIGINAL ARTICLES:

2018

Feldman A, Eder SK, Felder TK, Paulweber B, Zandanell S, Stechemesser L, Schranz M, Strebinger G, Huber-Schönauer U, Niederseer D, Patsch W, Weghuber D, Tevini J, Datz C, Aigner E. "Clinical and metabolic characterization of obese subjects without non-alcoholic fatty liver: a targeted metabolomics approach." Diabetes Metab. 2018 Sep 25. pii: S1262-3636(18)30174-5. doi: 10.1016/j.diabet.2018.09.003. [Epub ahead of print]

Kump P, Hassan C, Spada C, Brownstone E, Datz C, Haefner M, Renner F, Schoefl R, Schreiber F. "Efficacy and safety of a new low-volume PEG with citrate and simethicone bowel preparation for colonoscopy (Clensia): a multicenter randomized observer-blind clinical trial vs. a low-volume PEG with ascorbic acid (PEG-ASC)". Endosc Int Open. 2018 Aug;6(8):E907-E913. doi: 10.1055/a-0624-2266. Epub 2018 Aug 1. 

Strnad P, Buch S, Hamesch K, Fischer J, Rosendahl J, Schmelz R, Brueckner S, Brosch M, Heimes CV, Woditsch V, Scholten D, Nischalke HD, Janciauskiene S, Mandorfer M, Trauner M, Way MJ, McQuillin A, Reichert MC, Krawczyk M, Casper M, Lammert F, Braun F, von Schönfels W, Hinz S, Burmeister G, Hellerbrand C, Teufel A, Feldman A, Schattenberg JM, Bantel H, Pathil A, Demir M, Kluwe J, Boettler T, Ridinger M, Wodarz N, Soyka M, Rietschel M, Kiefer F, Weber T, Marhenke S, Vogel A, Hinrichsen H, Canbay A, Schlattjan M, Sosnowsky K, Sarrazin C, von Felden J, Geier A, Deltenre P, Sipos B, Schafmayer C, Nothnagel M, Aigner E, Datz C, Stickel F, Morgan MY, Hampe J, Berg T, Trautwein C. "Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosis." Gut. 2018 Aug 1. pii: gutjnl-2018-316228. doi: 10.1136/gutjnl-2018-316228. [Epub ahead of print] 

Schlossberger V, Worni M, Kihm C, Montani M, Datz C, Hampe J, Stickel F. "Plasma Levels of K18 Fragments Do Not Correlate with Alcoholic Liver Fibrosis." Gut Liver. 2018 Jul 5. doi: 10.5009/gnl18037. [Epub ahead of print]  

Aigner E, Feldman A, Neureiter D, Datz C, Ratziu V, Paulweber B. "Benefit of Treatment With Sebelipase-Alfa in a 63-Year-Old Patient With Advanced Liver and Atherosclerotic Disease Due to Lysosomal Acid Lipase Deficiency (LAL-D)". Am J Gastroenterol. 2018 Mar;113(3):443-445. doi: 10.1038/ajg.2017.486.


 

2017

Dolak W, Bilgilier C, Stadlmann A, Leiner J, Püspök A, Plieschnegger W, Siebert F, Wewalka F, Schöfl R, Huber-Schönauer U, Datz C, Biowski-Frotz S, Högenauer C, Schrutka-Kölbl C, Makristathis A, Schöniger-Hekele M, Steininger C; Austrian Helicobacter Pylori Study Group. "A multicenter prospective study on the diagnostic performance of a new liquid rapid urease test for the diagnosis of Helicobacter pylori infection."  Gut Pathog. 2017 Dec 22;9:78. doi: 10.1186/s13099-017-0226-5. eCollection 2017.

Kozbial K, Moser S, Al-Zoairy R, Schwarzer R, Datz C, Stauber R, Laferl H, Strasser M, Beinhardt S, Stättermayer AF, Gschwantler M, Zoller H, Maieron A, Graziadei I, Trauner M, Steindl-Munda P, Hofer H, Ferenci P. "Follow-up of sustained virological responders with hepatitis C and advanced liver disease after interferon/ribavirin-free treatment."
Liver Int. 2017 Nov 14. doi: 10.1111/liv.13629. [Epub ahead of print]

Dejaco C, Stadlmayr A, Duftner C, Trimmel V, Husic R, Krones E, Zandieh S, Husar-Memmer E, Zollner G, Hermann J, Gretler J, Lackner A, Ficjan A, Datz C, Axman R, Zwerina J. "Ultrasound verified inflammation and structural damage in patients with hereditary haemochromatosis-related arthropathy." Arthritis Res Ther. 2017 Oct 24;19(1):243. doi: 10.1186/s13075-017-1448-0.

Reiberger T, Püspök A, Schoder M, Baumann-Durchschein F, Bucsics T, Datz C, Dolak W, Ferlitsch A, Finkenstedt A, Graziadei I, Hametner S, Karnel F, Krones E, Maieron A, Mandorfer M, Peck-Radosavljevic M, Rainer F, Schwabl P, Stadlbauer V, Stauber R, Tilg H, Trauner M, Zoller H, Schöfl R, Fickert P. "Austrian consensus guidelines on the management and treatment of portal hypertension" (Billroth III). Wien Klin Wochenschr. 2017 Nov;129(Suppl 3):135-158. doi: 10.1007/s00508-017-1262-3. Epub 2017 Oct 23.

Bilgilier C, Stadlmann A, Makristathis A, Thannesberger J, Kastner MT, Knoflach P, Steiner P, Schöniger-Hekele M, Högenauer C, Blesl A, Datz C, Huber-Schönauer U, Schöfl R, Wewalka F, Püspök A, Mitrovits N, Leiner J, Tilg H, Effenberger M, Moser M, Siebert F, Hinterberger I, Wurzer H, Stupnicki T, Watzinger N, Gombotz G, Hubmann R, Klimpel S, Biowski-Frotz S, Schrutka-Kölbl C, Graziadei I, Ludwiczek O, Kundi M, Hirschl AM, Steininger C; Austrian Helicobacter Study Group of the Austrian Society of Gastroenterology and Hepatology. "Prospective multicentre clinical study on inter- and intrapatient genetic variability for antimicrobial resistance of Helicobacter pylori." Clin Microbiol Infect. 2017 Jun 29. pii: S1198-743X(17)30349-X. doi: 10.1016/j.cmi.2017.06.025. [Epub ahead of print]

Niederseer D, Stadlmayr A, Huber-Schönauer U, Plöderl M, Schmied C, Lederer D, Patsch W, Aigner E, Datz C.; "Cardiovascular Risk and Known Coronary Artery Disease Are Associated With Colorectal Adenoma and Advanced Neoplasia" J Am Coll Cardiol. 2017 May 9;69(18):2348-2350. doi: 10.1016/j.jacc.2017.02.065. 

Stickel F, Datz C, Hampe J, Bataller R. "Erratum: Pathophysiology and Management of Alcoholic Liver Disease: Update 2016" Gut Liver. 2017 May 15;11(3):447. doi: 10.5009/gnl11031.

Stickel F, Datz C, Hampe J, Bataller R. "Pathophysiology and Management of Alcoholic Liver Disease: Update 2016" Gut Liver. 2017 Mar 15;11(2):173-188. doi: 10.5009/gnl16477. Review.

Zhang W, Feng Q, Wang C, Zeng X, Du Y, Lin L, Wu J, Fu L, Yang K, Xu X, Xu H, Zhao Y, Li X, Schoenauer UH, Stadlmayr A, Saksena NK, Tilg H, Datz C, Liu X. "Characterization of the B Cell Receptor Repertoire in the Intestinal Mucosa and of Tumor-Infiltrating Lymphocytes in Colorectal Adenoma and Carcinoma." J Immunol. 2017 Mar 27. pii: 1602039. doi: 10.4049/jimmunol.1602039. [Epub ahead of print]

Yu J, Feng Q, Wong SH, Zhang D, Liang QY, Qin Y, Tang L, Zhao H, Stenvang J, Li Y, Wang X, Xu X, Chen N, Wu WK, Al-Aama J, Nielsen HJ, Kiilerich P, Jensen BA, Yau TO, Lan Z, Jia H, Li J, Xiao L, Lam TY, Ng SC, Cheng AS, Wong VW, Chan FK, Xu X, Yang H, Madsen L, Datz C, Tilg H, Wang J, Brünner N, Kristiansen K, Arumugam M, Sung JJ, Wang J. "Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer". Gut. 2017 Jan;66(1):70-78. doi: 10.1136/gutjnl-2015-309800. Epub 2015 Sep 25.

Stättermayer AF, Traussnigg S, Aigner E, Kienbacher C, Huber-Schönauer U, Steindl-Munda P, Stadlmayr A, Wrba F, Trauner M, Datz C, Ferenci P.; "Low hepatic copper content and PNPLA3 polymorphism in non-alcoholic fatty liver disease in patients without metabolic syndrome". J Trace Elem Med Biol. 2017 Jan;39:100-107. doi: 10.1016/j.jtemb.2016.08.006. Epub 2016 Aug 20.

Koji Taniguchi, Toshiro Moroishi, Petrus R. de Jong, Michael Krawczyk, Britta Moyo Grebbin, Huiyan Luo, Ruihua Xu, Nicole Golob-Schwanzl, Caroline Schweiger, Kepeng Wang, Guiseppe Di Caro, Ying Feng, Eric Fearon, Eyal Raz, Henner F. Farin, Kun-Liang Guan, Johannes Haybäck, Christian Datz, Kang Zhang, Michael Karin; "A YAP-IL6ST auto regulatory loop activated on APC loss controls colonic tumorigenesis"; Proc Natl Acad Sci U S A. 2017 Feb 14;114(7):1643-1648. doi: 10.1073/pnas.1620290114. Epub 2017 Jan 27.

Lars Stechemesser, Sebastian K. Eder, Andrej Wagner, Wolfgang Patsch, Alexandra Feldmann, Michael Strasser, Simon Auer, David Niederseer, Ursula Huber-Schönauer Bernhard Paulweber, Stephan Zandanell, Sandra Ruhaltinger, Daniel Weghuber, Elisabeth Haschkke-Becher, Christoph rabmer, Eva Rohde, Christian Datz, Thomas K. Felder, Elmar Aigner; "Metabolomic profiling identifies potential pathways involved in the interaction of iron homeostasis with glucose metabolism"; Mol Metab. 2016 Oct 31;6(1):38-47. doi: 10.1016/j.molmet.2016.10.006. eCollection 2016 Oct 31.



2016

Datz C, Müller E, Aigner E.; "Iron overload and nonalcoholic fatty liver disease". Minerva Endocrinol. 2017 Jun;42(2):173-183. doi: 10.23736/S0391-1977.16.02565-7. Epub 2016 Nov 11.

Alexandra Feldmann, Christian Datz und Elmar Aigner; "Letter to the Editor (Response to Dr. Braillon)"; Am J Gastroenterol. 2017 Mar;112(3):512. doi: 10.1038/ajg.2016.581.

Feldman A, Eder SK, Felder TK, Kedenko L, Paulweber B, Stadlmayr A, Huber-Schönauer U, Niederseer D, Stickel F, Auer S, Haschke-Becher E, Patsch W, Datz C, Aigner E.;  "Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver". Am J Gastroenterol. 2017 Jan;112(1):102-110. doi: 10.1038/ajg.2016.318. Epub 2016 Aug 16.

Werner S, Krause F, Rolny V, Strobl M, Morgenstern D, Datz C, Chen H, Brenner H. "Evaluation of a 5-Marker Blood Test for Colorectal Cancer Early Detection in a Colorectal Cancer Screening Setting". Clin Cancer Res. 2015 Nov 11. Clin Cancer Res. 2016 Apr 1;22(7):1725-33. doi: 10.1158/1078-0432.CCR-15-1268. Epub 2015 Nov 11.

Burza MA, Motta BM, Mancina RM, Pingitore P, Pirazzi C, Lepore SM, Spagnuolo R, Doldo P , Russo C, Lazzaro V, Fischer J, Berg T, Aghemo A, Cheroni C, De Francesco R, Fargion S, Colombo M, Datz C, Stickel F, Valenti L, Romeo S.; "DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection". Hepatology. 2016 Feb;63(2):418-27. doi: 10.1002/hep.28322. Epub 2015 Dec 18. Free PMC Article 

Strasser M, Stadlmayr A, Haufe H, Stickel F, Ferenci P, Patsch W, Feldman A, Weghuber D, Datz C, Aigner E. "Natural course of subjects with elevated liver tests and normal liver histology." Liver Int. 2016 Jan;36(1):119-25. doi: 10.1111/liv.12935. Epub 2015 Sep 6.



2015

Buch S, Stickel F, Trépo E, Way M, Herrmann A, Nischalke HD, Brosch M, Rosendahl J, Berg T, Ridinger M, Rietschel M, McQuillin A, Frank J, Kiefer F, Schreiber S, Lieb W, Soyka M, Semmo N, Aigner E, Datz C, Schmelz R, Brückner S, Zeissig S, Stephan AM, Wodarz N, Devière J, Clumeck N, Sarrazin C, Lammert F, Gustot T, Deltenre P, Völzke H, Lerch MM, Mayerle J, Eyer F, Schafmayer C, Cichon S, Nöthen MM, Nothnagel M, Ellinghaus D, Huse K, Franke A, Zopf S, Hellerbrand C, Moreno C, Franchimont D, Morgan MY, Hampe J. A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis. Nat Genet. 2015 Dec;47(12):1443-8. doi: 10.1038/ng.3417. Epub 2015 Oct 19.

 

Ebner S, Mangge H, Langhof H, Halle M, Siegrist M, Aigner E, Paulmichl K, Paulweber B, Datz C, Sperl W, Kofler B, Weghuber D. Mitochondrial Haplogroup T Is Associated with Obesity in Austrian Juveniles and Adults. PLoS One. 2015 Aug 31;10(8):e0135622. doi: 10.1371/journal.pone.0135622. eCollection 2015.

Strasser M, Stadlmayr A, Haufe H, Stickel F, Ferenci P, Patsch W, Feldman A, Weghuber D, Datz C, Aigner E. Natural course of subjects with elevated liver tests and normal liver histology. Liver Int. 2016 Jan;36(1):119-25. doi: 10.1111/liv.12935. Epub 2015 Sep 6. 

Stickel F, Hampe J, Trépo E, Datz C, Romeo S. PNPLA3 genetic variation in alcoholic steatosis and liver disease progression. Hepatobiliary Surg Nutr. 2015 Jun;4(3):152-60. doi: 10.3978/j.issn.2304-3881.2014.11.04. Review.

Aigner E, Stadlmayr A, Huber-Schönauer U, Zwerina J, Husar-Memmer E, Niederseer D, Eder SK, Stickel F, Pirich C, Schett G, Patsch W, Datz C. Parathyroid Hormone is Related to Dysplasia and a Higher Rate of Distal Colorectal Adenoma in Women but Not Men. Horm Cancer. 2015 Aug;6(4):153-60. doi: 10.1007/s12672-015-0227-0. Epub 2015 May 29.

Zelzer S, Mangge H, Pailer S, Ainoedhofer H, Kieslinger P, Stojakovic T, Scharnagl H, Prüller F, Weghuber D, Datz C, Haybaeck J, Obermayer-Pietsch B, Trummer C, Gostner J, Gruber HJ. Oxidized LDL Is Strictly Limited to Hyperthyroidism Irrespective of Fat Feeding in Female Sprague Dawley Rats. Int J Mol Sci. 2015 May 21;16(5):11689-98. doi: 10.3390/ijms160511689.

Feng Q*, Liang S*, Jia H*, Stadlmayr A*, Tang L*, Lan Z, Zhang D, Xia H, Xu X, Jie Z, Su L, Li X, Li X, Li J, Xiao L, Huber-Schönauer U, Niederseer D, Xu X, Al-Aama J, Yang H, Wang J, Kristiansen K, Arumugam M, Tilg H*, Datz C*, Wang J*. Gut microbiome development along the colorectal adenoma–carcinoma sequence. Nature Communications 2015. 6, 6528 (* these authors contributed equally to this work)

Aigner E, Weiss G, Datz C. Dysregulation of iron and copper homeostasis in nonalcoholic fatty liver. World J Hepatol. 2015 Feb 27;7(2):177-88.

Stättermayer AF, Traussnigg S, Dienes HP, Aigner E, Stauber R, Lackner K, Hofer H, Stift J, Wrba F, Stadlmayr A, Datz C, Strasser M, Maieron A, Trauner M, Ferenci P. Hepatic steatosis in Wilson disease - role of copper and PNPLA3 mutations. J Hepatol. 2015 Feb 9. pii: S0168-8278(15)00071-9. doi: 10.1016/j.jhep.2015.01.034. [Epub ahead of print]

Stadlmayr A, Aigner E, Huber-Schönauer U, Niederseer D, Zwerina J, Husar-Memmer E, Hohla F, Schett G, Patsch W, Datz C. Relations of vitamin D status, gender and type 2 diabetes in middle-aged Caucasians. Acta Diabetol. 2015 Feb;52(1):39-46.

Mangge H, Zelzer S, Meinitzer A, Stelzer I, Schnedl WJ, Weghuber D, Fuchs D, Postolache TT, Aigner E, Datz C, Reininghaus EZ. 25OH-Vitamin D3 Levels in Obesity and Metabolic Syndrome-Unaltered in Young and not Correlated to Carotid IMT in all Ages. Curr Pharm Des. 2015 Jan 5. [Epub ahead of print]

Niederseer D, Ramsauer T, Seitlinger G. Madelung’sche Deformität der Hand – eine seltene Blickdiagnose. Ärzte Woche 2015 1-2; 13



2014

Niederseer D, Niebauer J. Cardiovascular Risk-Benefit Ratio of Alpine Skiing in Recreational Skiers. Jahrbuch 2014 Österreichische Gesellschaft für Alpin- und Höhenmedizin, Jubiläumsausgabe 25 edited by W.Schobersberger, B.Schobersberger, G.Suman, W.Domej, 12/2014: 185-203; Österreichische Gesellschaft für Alpin- und Höhenmedizin., ISBN: 978-3-9501312-4-6

Aigner E, Stadlmayr A, Huber-Schönauer U, Zwerina J, Husar-Memmer E, Niederseer D, Trauner M, Heuberger A, Hohla F, Schett G, Patsch W, Datz C. Gender- and site-specific differences of colorectal neoplasia relate to vitamin D. Aliment Pharmacol Ther. 2014 Dec;40(11-12):1341-8.

Niederseer D, Richter SA, Neunhäuserer D, Lamprecht B, Buist SA, Studnicka M, Niebauer J. Symptomatic chronic obstructive pulmonary disease in clinical trials and in a population-based study. Sleep Breath. 2014 Nov 27. [Epub ahead of print]

van Ginkel S, Amami M, Dela F, Niederseer D, Narici MV, Niebauer J, Scheiber P, Müller E, Flück M. Adjustments of muscle capillarity but not mitochondrial protein with skiing in the elderly. Scand J Med Sci Sports. 2014 Sep 28. [Epub ahead of print]

Plöderl M, Fartacek C, Kunrath S, Pichler EM, Fartacek R, Datz C, Niederseer D. Nothing like Christmas-suicides during Christmas and other holidays in Austria. Eur J Public Health. 2014 Sep 22. pii: cku169. [Epub ahead of print]

Aigner E, Feldman A, Datz C. Obesity as an emerging risk factor for iron deficiency. Nutrients. 2014 Sep 11;6(9):3587-600.

Niederseer D, Mörtl H, Liebensteiner M C, Egger A, Thaler C W, Plöderl M, Niebauer J, Raschner C. General Fatigue and Joint Position Sense in Male Elite Handball Players. Dt Z Sportmed 2014; 65(6):149 - 153.

Stickel F, Buch S, Zoller H, Hultcrantz R, Gallati S, Österreicher C, Finkenstedt A, Stadlmayr A, Aigner E, Sahinbegovic E, Sarrazin C, Schafmayer C, Braun F, Erhart W, Nothnagel M, Lerch MM, Mayerle J, Völzke H, Schaller A, Kratzer W, Boehm BO, Sipos B, D'Amato M, Torkvist L, Stal P, Arlt A, Franke A, Becker T, Krawczak M, Zwerina J, Berg T, Hinrichsen H, Krones E, Dejaco C, Strasser M, Datz C, Hampe J. Evaluation of genome-wide loci of iron metabolism in hereditary hemochromatosis identifies PCSK7 as a host risk factor of liver cirrhosis. Hum Mol Genet. 2014 Jul 15;23(14):3883-90.

Husar-Memmer E, Stadlmayr A, Datz C, Zwerina J. HFE-related hemochromatosis: an update for the rheumatologist. Curr Rheumatol Rep. 2014 Jan;16(1):393.

Beinhardt S, Leiss W, Stättermayer AF, Graziadei I, Zoller H, Stauber R, Maieron A, Datz C, Steindl-Munda P, Hofer H, Vogel W, Trauner M, Ferenci P. Long-term outcomes of patients with Wilson disease in a large Austrian cohort. Clin Gastroenterol Hepatol. 2014 Apr;12(4):683-9.

Aigner E, Niederseer D, Patsch W, Datz C, Müller E, Niebauer J. Alpine skiing improves copper imbalance in untrained middle-aged subjects: a randomized controlled trial. Experimental and clinical cardiology 2014; 20(1):428-38.


2013

Niederseer D, Stadlmayr A, Aigner E, Datz C. Re: Physical activity and risk of inflammatory bowel disease: prospective study from the Nurses´ Health Study cohorts. BMJ. online 22 November 2013 (http://www.bmj.com/content/347/bmj.f6633/rr/673893)

Niederseer D, Thaler CW, Niederseer M, Niebauer J. Mismatch between heart failure patients in clinical trials and the real world. Int J Cardiol. 2013 Oct 3;168(3):1859-65. PMID: 23352093

Neunhäuserer D, Sturm J, Baumgartlinger MM, Niederseer D, Ledl-Kurkowski E, Steidle E, Plöderl M, Fartacek C, Kralovec K, Fartacek R, Niebauer J. Hiking in suicidal patients: neutral effects on markers of suicidality. Am J Med. 2013 Oct;126(10):927-30. PMID: 23953873

Niederseer D, Thaler CW, Egger A, Niederseer MC, Plöderl M, Niebauer J. Watching soccer is not associated with an increase in cardiac events. Int J Cardiol. 2013 [Epub ahead of print] PMID: 24182671

Ramsauer T, Seitlinger G, Niederseer D. Seltene Knieschmerzursache nach Knietotalendoprothesenimplantation [Rare cause of knee pain after total knee arthroplasty]. Der Orthopäde. 2013 Nov;42(11):969-70. PMID: 24190241

Egger A, Niederseer D, Diem G, Finkenzeller T, Ledl-Kurkowski E, Forstner R, Pirich C, Patsch W, Weitgasser R, Niebauer J. Different types of resistance training in type 2 diabetes mellitus: effects on glycaemic control, muscle mass and strength. Eur J Prev Cardiol. 2013 Dec;20(6):1051-60.

Beinhardt S, Anna Payer B, Datz C, Strasser M, Maieron A, Dorn L, Grilnberger-Franz E, Dulic-Lakovic E, Stauber R, Laferl H, H Aberle J, Holzmann H, Krall C, Vogel W, Ferenci P, Hofer H. A Diagnostic Score for the Prediction of Spontaneous Resolution of Acute Hepatitis C Virus Infection; J Hepatol. 2013 Jul 10; [Epub ahead of print]; PMID: 23850880

Scherzer TM, Stättermayer AF, Stauber R, Maieron A, Strasser M, Laferl H, Schwarzer R, Datz C, Rutter K, Beinhardt S, Munda P, Hofer H, Ferenci P; Effect of gender and ITPA polymorphisms on ribavirin-induced anemia in chronic hepatitis C patients; J Hepatol. 2013 Jul 10; [Epub ahead of print]; PMID: 23850877

Strasser M, Aigner E, Schmid I, Stadlmayr A, Niederseer D, Patsch W, Datz C.; Risk of hepatitis C virus transmission from patients to healthcare workers: a prospective observational study. Infect Control Hosp Epidemiol. 2013 Jul; Epub 2013 May 22.; PMID: 237390855

Nell-Duxneuner V, Axmann R, Husar-Memmer E, Dallos T, Datz C, Stadlmayr A, Aigner E, Englbrecht M, Schett G, Zwerina J.;VCAM-1 serum levels are associated with arthropathy in hereditary haemochromatosis;Ann Rheum Dis. 2013 Apr 18. [Epub ahead of print];PMID: 23599437 [PubMed - as supplied by publisher]

Peck-Radosavljevic M, Angermayr B, Datz C, Ferlitsch A, Ferlitsch M, Fuhrmann V, Häfner M, Kramer L, Maieron A, Payer B, Reiberger T, Stauber R, Steininger R, Trauner M, Thurnher S, Ulbrich G, Vogel W, Zoller H, Graziadei I; Austrian consensus on the definition and treatment of portal hypertension and its complications (Billroth II).for the Austrian Society of Gastroenterology and Hepatology (ÖGGH).Wien Klin Wochenschr. 2013 Apr;125(7-8):200-219; Epub 2013 Apr 12; PMID: 23579878

Dallos T, Sahinbegovic E, Stamm T, Aigner E, Axmann R, Stadlmayr A, Englbrecht M, Datz C, Schett G, Zwerina J. Idiopathic hand osteoarthritis vs haemochromatosis arthropathy--a clinical, functional and radiographic study. Rheumatology (Oxford). 2013 Jan 12. [Epub ahead of print] PubMed PMID: 23315789.

Datz C
, Felder TK, Niederseer D, Aigner E. Iron homeostasis in the Metabolic Syndrome. Eur J Clin Invest. 2013 Feb;43(2):215-224. doi: 10.1111/eci.12032. Epub 2013 Jan 7. PubMed PMID: 23289518.

Tschentscher M, Niederseer D, Niebauer J. Health benefits of nordic walking: a systematic review. Am J Prev Med. 2013 Jan;44(1):76-84. doi: 10.1016/j.amepre.2012.09.043. PubMed PMID: 23253654.

 

 


 


2012

Aigner F, Conrad F, Haunold I, Pfeifer J, Salat A, Wunderlich M; Konsensusgruppe der Arbeitsgemeinschaft für Coloproktologie (ACP) der Österreichischen Gesellschaft für Chirurgie, Fortelny R, Fritsch H, Glöckler M, Hauser H, Heuberger A, Karner-Hanusch J, Kopf C, Lechner P, Riss S, Roka S, Scheyer M. [Consensus statement haemorrhoidal disease]. Wien Klin Wochenschr. 2012 Mar;124(5-6):207-19. doi: 10.1007/s00508-011-0107-8. Epub 2012 Mar 2. PubMed PMID: 22378598.

Adlbrecht C, Aigner E, Bellón JM, Bouloukaki I, Bouzas-Mosquera A, Carrilho AJF, Chang KC, Chattipakorn N, Chattipakorn SC, Chen YJ, Chung YC, Colah R, Datz C, Frøkjær JB, Fujimori S, Georgiadou P, Grion CM, Hsu CP, Hülsmann M, Hung MJ, Hung MY, Iliodromitis EK, Lang IM, Lee TI, März W, Nair SB, Pascual G, Peteiro J, Sakamoto C, Satomura A, Schiza SE, Stärkel P, Stojakovic T, Vesely DL, Walters DL, Yilmaz Y. Research update for articles published in EJCI in 2010. Eur J Clin Invest. 42, 11, November 2012, 1149–1164 Article first published online : 3 OCT 2012, DOI: 10.1111/eci.12001

Rick FG, Seitz S, Schally AV, Szalontay L, Krishan A, Datz C, Stadlmayr A, Buchholz S, Block NL, Hohla F. GHRH antagonist when combined with cytotoxic agents induces S-phase arrest and additive growth inhibition of human colon cancer. Cell Cycle. 2012 Nov 15;11(22):4203-10. doi: 10.4161/cc.22498. Epub 2012 Oct 24. PubMed PMID: 23095641; PubMed Central PMCID: PMC3524216.


Grivennikov SI, Wang K, Mucida D, Stewart CA, Schnabl B, Jauch D, Taniguchi K, Yu GY, Osterreicher CH, Hung KE, Datz C, Feng Y, Fearon ER, Oukka M, Tessarollo L, Coppola V, Yarovinsky F, Cheroutre H, Eckmann L, Trinchieri G, Karin M. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature. 2012 Nov 8;491(7423):254-8. doi: 10.1038/nature11465. PubMed PMID: 23034650.


Aigner E, Felder TK, Oberkofler H, Hahne P, Auer S, Soyal S, Stadlmayr A, Schwenoha K, Pirich C, Hengster P, Datz C, Patsch W. Glucose acts as a regulator of serum iron by increasing serum hepcidin concentrations. J Nutr Biochem. 2013 Jan;24(1):112-7. doi: 10.1016/j.jnutbio.2012.02.017. Epub 2012 Jul 21. PubMed PMID: 22819549.


Rick FG, Buchholz S, Schally AV, Szalontay L, Krishan A, Datz C, Stadlmayr A, Aigner E, Perez R, Seitz S, Block NL, Hohla F. Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancers. Cell Cycle. 2012 Jul 1;11(13):2518-25. doi: 10.4161/cc.20900. Epub 2012 Jul 1. PubMed PMID: 22751419; PubMed Central PMCID: PMC3404878.


Aigner E, Datz C. The Role of Impaired Iron and Copper Metabolism in Patients with Non-alcoholic Fatty Liver Disease – Diagnostic and Therapeutic Implications. Eur Gastroenterol Hepatol Review. 2012;8(2):105-110


Stättermayer AF, Rutter K, Beinhardt S, Scherzer TM, Stadlmayr A, Hofer H, Wrba F, Steindl-Munda P, Krebs M, Datz C, Trauner M, Ferenci P. Association of the IL28B genotype with insulin resistance in patients with chronic hepatitis C. J Hepatol. 2012 Sep;57(3):492-8. doi: 10.1016/j.jhep.2012.04.036. Epub 2012 May 24. PubMed PMID: 22634340.


Beinhardt S, Aberle JH, Strasser M, Dulic-Lakovic E, Maieron A, Kreil A, Rutter K, Staettermayer AF, Datz C, Scherzer TM, Strassl R, Bischof M, Stauber R, Bodlaj G, Laferl H, Holzmann H, Steindl-Munda P, Ferenci P, Hofer H. Serum level of IP-10 increases predictive value of IL28B polymorphisms for spontaneous clearance of acute HCV infection. Gastroenterology. 2012 Jan;142(1):78-85.e2. doi: 10.1053/j.gastro.2011.09.039. Epub 2011 Sep 24. PubMed PMID: 22192885.


Seitlinger G, Scheurecker G, Högler R, Labey L, Innocenti B, Hofmann S. Tibial tubercle-posterior cruciate ligament distance: a new measurement to define the position of the tibial tubercle in patients with patellar dislocation. Am J Sports Med. 2012 May;40(5):1119-25. doi: 10.1177/0363546512438762. Epub 2012 Mar 13. PubMed PMID: 22415209.


Hell M, Sickau K, Chmelizek G, Kern JM, Maass M, Huhulescu S, Allerberger F. Absence of Clostridium difficile in asymptomatic hospital staff. Am J Infect Control. 2012 Dec;40(10):1023-4. doi: 10.1016/j.ajic.2012.01.018. Epub 2012 May 8. PubMed PMID: 22572458.


Hofmann J, Zotter H, Kerbl R. How to dress as a paediatrician? Acta Paediatr. 2012 Dec;101(12):1260-4. doi: 10.1111/apa.12020. Epub 2012 Oct 8. PubMed PMID:
22962859.


Seitlinger G, Beitzel K, Scheurecker G, Imhoff A, Hofmann S. Das schmerzhafte Patellofemoralgelenk. Der Orthopäde. 2012, 04; 40(4):353-370. DOI:10.1007/s00132-011-1752-3


Seitlinger G, Scheurecker G, Högler R, Kramer J, Hofmann S. Bildgebende Diagnostik des Patellofemoralgelenks. Arthroskopie 2012, 04; 23(3):176-183. DOI:10.1007/s00142-010-0567-2


Seitlinger G, Schafelner E. Partial Knee Solution – eine halbe Sache?
JATROS Orthopädie und Rheumatologie 2012, 03; 17:10-13.


Ramsauer T. Operationsverfahren in der Rheumaorthopädie. Hand- und Handgelenksoperationen beim Rheumatiker. arthritis + rheuma 2012, 32; 300-305


Niederseer D, Niebauer J. Ausdauer- und Krafttraining bei Patienten mit Diabetes mellitus Typ 2 und Herzinsuffizienz [Aerobic and strength training in patients with diabetes mellitus type 2 and heart failure]. Herz. 2012 Aug;37(5):499-507. doi: 10.1007/s00059-012-3635-8. PubMed PMID: 22669312.


Sturm J, Plöderl M, Fartacek C, Kralovec K, Neunhäuserer D, Niederseer D, Hitzl W, Niebauer J, Schiepek G, Fartacek R. Physical exercise through mountain hiking in high-risk suicide patients. A randomized crossover trial. Acta Psychiatr Scand. 2012 Dec;126(6):467-75. doi: 10.1111/j.1600-0447.2012.01860.x. Epub 2012 Apr 6. PubMed PMID: 22486584.


Niederseer D, Möller J, Niebauer J. Increased rates of myocardial infarction and deaths in men after sexual activity. Int J Cardiol. 2012 Apr 19;156(2):234-5. doi: 10.1016/j.ijcard.2012.01.036. Epub 2012 Feb 14. PubMed PMID: 22336258.


Niederseer D, Niebauer J. Bedeutung des körperlichen Trainings bei herzkranken Diabetiker. Herzmedizin 2012, 29:2, 6-13

 

 


 

2011

Impact of IL28B on treatment outcome in hepatitis C virus G1/4 patients receiving response-guided therapy with peginterferon alpha-2a (40KD)/ribavirin.
Scherzer TM, Stättermayer AF, Strasser M, Laferl H, Maieron A, Stauber R, Datz C, Dulic-Lakovic E, Steindl-Munda P, Hofer H, Ferenci P. Hepatology. 2011 Nov;54(5);1518-26. doi.1002/hep.24546

Bleeding dieulafoy lesions of the samall bowel: a systematic study on epidemiology and efficacy of enteroscopic treatment.
Emina Dulic-Lakovic, Melisa Dulic, Dietmar Hubner, Harry Fuchssteiner, Thomas Pachofszky, Bernhard Stadler, Andreas Maieron, Hubert Schwaighofer, Prof. of Medicine, Andreas Püspök, Prof. of Medicine, Thomas Haas, Gottfried Gahbauer, Christian Datz, Prof. of Medicine, Parnaz Ordubadi, Antje Holzäpfel, Michael Gschwantler, Prof. of Medicine for the Austrian Dieulafoy-Bleeding Study Group. Gastrointestinal Endoscopy, 2011 Sep;74(3):573-80 EPUB 2011 Jul 29.

Transcription factor Fra-1 induces cholangitis and liver fibrosis.
Kireva T, Erhardt A, Tiegs G, Tilg H, Denk H, Haybaeck J, Aigner E, Moschen A, Distler JH, Schett G, Zwerina J. Hepatology. 2011 Apr;53(4):1287-97. doi: 10.1002/hep.24175.

Nonalcoholic fatty liver disease: an independent risk factor for colorectal neoplasia.
Stadlmayr A, Aigner E, Steger B, Scharinger L, Lederer D, Mayr A, Strasser M, Brunner E, Heuberger A, Hohla F, Steinwendner J, Patsch W, Datz C. Intern Med. 2011 Mar 17. doi: 10.1111/j.1365-2796.2011.02377.x. [Epub ahead of print]

Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians.
Stickel F, Buch S, Lau K, zu Schwabedissen HM, Berg T, Ridinger M, Rietschel M, Schafmayer C, Braun F, Hinrichsen H, Günther R, Arlt A, Seeger M, Müller S, Seitz HK, Soyka M, Lerch M, Lammert F, Sarrazin C, Kubitz R, Häussinger D, Hellerbrand C, Bröring D, Schreiber S, Kiefer F, Spanagel R, Mann K, Datz C, Krawczak M, Wodarz N, Völzke H, Hampe J. Hepatology. 2011 Jan; 53(1):86-95. doi: 10.1002/hep.24017. Epub 2010 Dec 7.

Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver.
Österreicher CH, Penz-Österreicher M, Grivennikov SI, Guma M, Koltsova EK, Datz C, Sasik R, Hardiman G, Karin M, Brenner DA. Proc Natl Acad Sci U S A. 2011 Jan 4;108(1):308-13. Epub 2010 Dec 20.

 


 

2010

Impact of IL28B Genotype on the Early and Sustained Virologic Response in Treatment-naďve Patients With Chronic Hepatitis C.
Stättermayer AF, Stauber R, Hofer H, Rutter K, Beinhardt S, Scherzer TM, Zinober K, Datz C, Maieron A, Dulic-Lakovic E, Kessler HH, Steindl-Munda P, Strasser M, Krall C, Ferenci P. Clin Gastroenterol Hepatol. 2010 Aug 20. [Epub ahead of print]

Musculoskeletal disease burden of hereditary hemochromatosis.
Sahinbegovic E, Dallos T, Aigner E, Axmann R, Manger B, Englbrecht M, Schöniger-Hekele M, Karonitsch T, Stamm T, Farkas M, Karger T, Stölzel U, Keyßer G, Datz C, Schett G, Zwerina J. Arthritis Rheum. 2010 Aug 18. [Epub ahead of print]

Validation of a radiographic scoring system for haemochromatosis arthropathy.
Dallos T, Sahinbegovic E, Aigner E, Axmann R, Schöniger-Hekele M, Karonitsch T, Stamm T, Farkas M, Karger T, Cavallaro A, Stölzel U, Keyßer G, Datz C, Schett G, Manger B, Zwerina J. Ann Rheum Dis. 2010 Aug 2. [Epub ahead of print]

Hereditary hemochromatosis as a risk factor for joint replacement surgery.
Sahinbegovic E, Dallos T, Aigner E, Axmann R, Engelbrecht M, Schöniger-Hekele M, Karonitsch T, Farkas M, Karger T, Willeit J, Stölzel U, Keysser G, Datz C, Kiechl S, Schett G, Zwerina J. Am J Med. 2010 Jul;123(7):659-62.

Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial.
Reinisch W, Angelberger S, Petritsch W, Shonova O, Lukas M, Bar-Meir S, Teml A, Schaeffeler E, Schwab M, Dilger K, Greinwald R, Mueller R, Stange EF, Herrlinger KR; International AZT-2 Study Group. Gut. 2010 Jun;59(6):752-9.

A Role for Low Hepatic Copper Concentrations in Nonalcoholic Fatty Liver Disease.
Aigner E, Strasser M, Haufe H, Sonnweber T, Hohla F, Stadlmayr A, Solioz M, Tilg H, Patsch W, Weiss G, Stickel F, Datz C. Am J Gastroenterol. 2010 Sep;105(9):1978-85. Epub 2010 Apr 20

Sedation training using a human patient simulator.
Hofmann N, Datz C, Schöchl H. Digestion. 2010;82(2): 115-7. Epub 2010 Apr 21.

Iron Stores, Liver Transaminase Levels and Metabolic Risk in Healthy Teenagers.
Elmar Aigner, Christina Hinz, Konrad Steiner, Bianca Rossmann, Johanna Pfleger, Florian Hohla, Barbara Steger, Andreas Stadlmayr, Wolfgang Patsch, and Christian Datz. Eur J Clin Invest. 2010 Feb;40(2):155-63. Epub 2009 Dec 27.

Targeted cytotoxic somatostatin analog AN-162 inhibits growth of human colon carcinomas and increases sensitivity of doxorubicin resistant murine leukemia cells.
Hohla F, Buchholz S, Schally AV, Krishan A, Rick FG, Szalontay L, Papadia A, Halmos G, Koster F, Aigner E, Datz C, Seitz S. Cancer Lett. 2010 Aug 1;294(1):35-42. Epub 2010 Feb 13.

Synovial immunopathology in haemochromatosis arthropathy.
Heiland GR, Aigner E, Dallos T, Sahinbegovic E, Krenn V, Thaler C, Weiss G, Distler JH, Datz C, Schett G, Zwerina J. Ann Rheum Dis. 2010 Jun;69(6):1214-9. Epub 2009 Nov 23.

Peginterferon alfa-2a/ribavirin for 48 or 72 weeks in hepatitis C genotypes 1 and 4 patients with slow virologic response.
Ferenci P, Laferl H, Scherzer TM, Maieron A, Hofer H, Stauber R, Gschwantler M, Brunner H, Wenisch C, Bischof M, Strasser M, Datz C, Vogel W, Löschenberger K, Steindl-Munda P; Austrian Hepatitis Study Group. Gastroenterology. 2010 Feb;138(2):503-12, 512.e1. Epub 2009 Nov 10.

 


 

2009

Microsomal triglyceride transfer protein (MTP) gene polymorphism and lipid metabolism in HCV infected patients.
Mirandola S, Österreicher CH, Marcolongo M, Datz C, Aigner E, Schlabrakowski A, Realdon S, Gerotto M, Alberti A, Stickel F. Liver International 2009, Apr 29 (4) 557-65.

Retinol-binding protein4 (RBP4) in polycystic ovary syndrome (PCOS) – association with steroid hormones and response to pioglitazone treatment.
E. Aigner, N. Brettenthaler, W. Patsch, C. Datz. J Clin Endocrinol 2009, Apr 94(4); 1229-35.

Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia.
I. Theurl, E. Aigner, M. Theurl, M. Nairz, M. Seifert, A. Schroll, T. Sonnweber, L. Eberwein, D.R. Witcher, A. T. Murphy, V. J. Wroblewski, E. Wurz, C. Datz, and G. Weiss. Diagnostic and therapeutic implications. Blood 2009,May 21;113(21):5277-86.

Hedgehog signaling is involved in differentiation of normal colonic tissue rather than in proliferation.
Alinger B, Kiesslich T, Datz C, Aberger F, Strasser F, Berr F, Dietze O, Kaserer K, Hauser-Kronberger C. Virchow Arch 2009, Apr 454 (4) 369-79.

GHRH antagonist causes DNA damage leading to Cell Cycle arrest and apoptosis in human colon cancer cells.
Florian Hohla, Stefan Buchholz, Andrew V. Schally, Stefan Seitz, Ferenc G. Rick, Luca Szalontay, Jozsef L. Varga, Marta Zarandi, Gabor Halmos, Irving Vidaurre, Awtar Krishan, Metin Kurtoglu, Sudhir Chandna, Elmar Aigner and Christian Datz. Cell Cycle. 2009 Oct 1;8(19):3149-56. Epub 2009 Oct 3.

Peginterferon Alfa-2a/Ribavirin for 48 or 72 Weeks in Hepatitis C Types 1 and 4 Patients With Slow Virologic Response.
Ferenci P, Laferl H, Scherzer TM, Maieron A, Hofer H, Stauber R, Gschwantler M, Brunner H, Wenisch C, Bischof M, Strasser M, Datz C, Vogel W, Löschenberger K, Steindl-Munda P; Austrian Hepatitis Study Group. Gastroenterology 2010; Feb;138(2):503-512.e1. Epub 2009 Nov 10

Synovial immunopathology in hemochromatosis arthropathy.
Ruiz Heiland G, Aigner E, Dallos T, Sahinbegovic E, Krenn V, Thaler C, Weiss G, Distler JH, Datz C, Schett G, Zwerina J. Ann Rheum Dis. 2009 Nov 23. Epub ahead of print

 


 

2008

Potential involvement of GHRH Receptor and its splice variants in the malignant transformation of esophageal and colonic mucosa.
Hohla F, Moder A, Mayrhauser U, Hauser-Kronberger C, Schally A, Varga J, Zarandi M, Buchholz S, Huber R, Aigner E, Ritter M, Datz C. Int J Oncol 2008 Jul(1):137-43.

Pathways underlaying iron accumulation in human Non Alcoholic Fatty Liver Disease (NAFLD).
Aigner E, Theurl I, Theurl M, Hauffe H , Strasser M, Dietze O, Datz C, Weiss G. Pathways underlaying iron accumulation in human Non Alcoholic Fatty Liver Disease (NAFLD). Am J Clin Nutr 2008, May ;87(5)1374-83.

A randomized, prospective trial of ribavirin 400 mg/day versus 800 mg/day in combination with peginterferon alfa-2a in hepatitis C virus genotypes 2 and 3. Hepatology.
Ferenci P, Brunner H, Laferl H, Scherzer TM, Maieron A, Strasser M, Fischer G, Hofer H, Bischof M, Stauber R, Gschwantler M, Steindl-Munda P, Staufer K, Löschenberger K; Austrian Hepatitis Study Group. 2008 Jun;47(6):1816-23.

Copper availability contributes to iron pertubations in human non-alcoholic fatty liver disease.
E. Aigner, I. Theurl, H. Haufe, M. Seifert, F. Hohla, L. Scharinger, F. Stickel, F.Mourlane, G. Weiss, C. Datz. Gastroenterology 2008, Aug;135(2):680-8.

Peginterferon alfa-2a and ribavirin for 24 weeks in hepatitis C type 1 and 4 patients with rapid virologic response.
Ferenci P, Laferl H, Scherzer TM, Maieron A, Gschwantler M, Brunner H, Hubmann R, Bischof M, Stauber R, Bauer B, Datz C, Löschenberger K, Formann E, Staufer K, Steindl-Munda P. Gastroenterology 2008, Aug;135(2):451-8.

Hyperferritinemia in non alcoholic fatty liver disease (NAFLD): clinical relevance and molecular mechanisms. Review article.
Aigner E and Datz C. Hepatitis Monthly 2008 Sep 15(3). 654-9 (citation in progress)

 


 

2007

ÖGGH-Konsensus zur Diagnose und Therapie der Virushepatitis 2005.
Datz C, Denk H, Ferenci P, Holzmann H, Kessler H, Munda P, Peck-Radosavljevic M, Renner F, Trauner M, Vogel W, Wrba F. J Gastroenterol Hepatol Erkr 1/2007

Significant morbidity and mortality in paid plasma donors infected with hepatitis C at plasma donation in the 1970ies.
Ferenci P, Ferenci S, Datz C, Rezmann I, Oberaigner W, Strauss R. J Hepatol 2007; 47(1):31-6.

Contribution of anti-cyclic citrullinated peptide and rheumatoid factor for the diagnosis of arthropathy in patients with hereditary hemochromatosis.
Aigner E, Schmid I, Österreicher C, Zwerina J, Schett G, Strasser M, Niksic F, Ramsauer T, Dorn U, Patsch W, Datz C. Ann Rheumatic Dis. 2007; 66:1249-51.

Growth inhibition of non small cell lung carcinoma by bombesin/grp antagonist is linked with a suppression of k-ras, cox-2 and pAkt.
Hohla F, Schally AV, Kanashiro CA, Buchholz S, Köster F, Heinrich E, Baker B, Kannadka C, Moder A, Datz C, Halmos G. PNAS 2007;104(47) :18671-76.

Diagnostik der obskuren gastrointestinalen Blutung- Stellenwert von Kapselendoskopie und Doppelballonenteroskopie.
Scharinger L, Aigner E, Datz C. J Gastroenterol Hepatol Erkr. 4/2007.

 


 

2006

Randomized, double-blind, placebo-controlled study of peginterferon alfa-2a plus ribavirin with or without amantadine in patients with chronic hepatitis C genotype 1 infection.
Ferenci P, Formann E, Laferl H, Gschwantler M, Hackl F, Brunner H, Hubmann R, Datz C, Stauber R, Steindl-Munda P, Kessler H, Klingler A, Gangl A for the Austrian Hepatitis Study Group. J Hepatol 2006;44:275-82.

Antagonists of Growth hormone releasing hormone decrease expression of K-ras, Cox-2 and pAkt in orthotopic non-small cell lung cancer and augment tumor inhibition when combined with Docetaxel.
Hohla F, Schally AV, Szepeshazi K, Varga JL, Groot K, Buchholz S, Köster F, Heinrich E, Halmos G, Rick FG, Kannadka C, Datz C, Kanashiro CA. PNAS 2006; (39)103:14513-18.

Liver microsomal triglyceride transfer protein (MTP) is involved in HCV related hepatic steatosis through genotype specific pathways.
Mirandola S, Realdon S, Jahangir I, , Gerotto M, Dal Pero F, Bortoletto G, Marcolongo M, Vario A, Datz C, Hussain M, Alberti A. Gastroenterology 2006; 130:1661-69.

 


 

2005

A functional polymorphism in the gluthatione-s-transferase p1 gene determines the progression to cirrhosis in patients with hereditary hemochromatosis.
Stickel F, Österreicher C, Datz C, Ferenci P, Distler J, Wrba F, Hellerbrand C, Schuppan D. Arch Int Med 2005, Sept 12;165(16):1835-40.

Suppression of hematopoesis during therapy with different INF-@ mono- and combination therapy regimes.
Schmid M, Kreil A, Jessner W, Homoncik M, Datz C, Gangl A, Ferenci F, Peck-Radosavljevic M. Gut 2005; 54:1014-1020.

TGF-ß gene polymorphism (Codon 25Arg-Pro) affects progression to cirrhosis in patients with hereditary hemochromatosis.
Österreicher C, Datz C, Stickel F, Hellerbrand C, Penz M, Hofer H, Wrba F, Penner E, Schuppan D, Ferenci P. Cytokine 2005, Jul 21;31(2):142-8.

Diagnostic value of quantitative hepatic copper determination in patients with wilson disease.
P. Ferenci, P. Munda-Steindl, W. Vogel, W. Jessner, M. Gschwantler, R. Stauber, C. Datz, F. Hackl, F.Wrba, P. Bauer, O. Lorenz. Clinical Gastroenterology and Hepatology 2005; 3(8):811-18.

Polymorphism of the myeloperoxidase promotor affects progression to cirrhosis in patients with hereditary hemochromatosis.
Österreicher C, Datz C, Stickel F, Hellerbrand C, Penz M, Hofer H, Wrba F, Penner E, Schuppan D, Ferenci P. J Hepatol 2005; 42:914-919.

 


 

2004

Iron regulates hepatitis C virus translation via stimulation of eIF 3 expression.
I. Theurl, H. Zoller, P. Obrist, C. Datz, F. Bachmann, R. Elliot, G.Weiss. J Infect Dis; 2004 Aug 15;190(4):819-25.

Induction treatment of chronic hepatitis C with daily interferon plus ribavirin plus amantadine in non-responders to interferon/ribavirin combination therapy.
Stauber R, Hofer H, Hackl F, Schütze K, Datz C, Hegenbarth K, Jessner W, Steindl-Munda P, Ferenci P. Wi Kli Wo 2004, Aug 31; 116(15-16):530-5.

Standardtherapie der chronischen Hepatitis C-Virusinfektion. Review article.
Datz C. J Gastroenterol Hepatol Erkr 2004; 2 (Sonderheft 1): S16-20.

Diese Webseite verwendet Cookies. Durch die Nutzung der Webseite stimmen Sie der Verwendung von Cookies zu. Mehr dazu